What we do
Valitacell develops biotechnology which allows companies to manufacture bio-therapeutic drugs faster and cheaper. Valitacell products allow users to select cells with greater regulatory confidence at the earliest possible stage during the drug development pathway. Valitacell is transforming the Cell Line Development process with simple, robust technologies.
Valitacell Awarded €2.02 million in H2020 Funding
Valitacell has been successful in winning €2.02 million in funding through the latest round of Horizon 2020 SME instrument Phase 2. The award will fund the advancement and commercialisation of Valitacell’s ‘ChemStress’ technology – a novel disruptive product which enables biopharmaceutical companies to manufacture life-saving drugs, cheaper, faster and with more regulatory confidence.